Ingen varer
Bemærk: Kan ikke leveres før jul.
Forventes på lager: 29-08-2025
Since 1972 when recombinant engineering was invented, over 500 therapeutic proteins have been approved. Today, biological drugs constitute almost 70% of all new drugs and are of biological origin. The first edition of this book dealt with biosimilars, the second focuses on new drugs yet limits to therapeutic proteins.
| Forlag | Taylor & Francis Ltd |
| Forfatter | Sarfaraz (Pharmaceutical Scientist Inc. Niazi |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | 2 ed |
| Udgivelsesdato | 29-08-2025 |
| Første udgivelsesår | 2025 |
| Illustrationer | 69 Tables, black and white; 35 Line drawings, color; 17 Line drawings, black and white; 4 Halftones, color; 1 Halftones, black and white; 39 Illustrations, color; 18 Illustrations, black and white |
| Originalsprog | United Kingdom |
| Sideantal | 408 |
| Indbinding | Paperback / softback |
| Forlag | Taylor & Francis Ltd |
| Sideoplysninger | 408 pages, 69 Tables, black and white; 35 Line drawings, color; 17 Line drawings, black and white; 4 |
| Mål | 254 x 178 |
| ISBN-13 / EAN-13 | 9781032490540 |